Open access
114
Views
40
CrossRef citations to date
0
Altmetric
Original Research
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 μg compared with tiotropium 18 μg in patients with COPD
Gregory Feldman1 S. Carolina Pharmaceutical Research, Spartanburg, SC, USACorrespondence[email protected]
, François Maltais2 Institut universitaire de cardiologie et de pneumologie de Québec, Quebec, QC, Canada
, Sanjeev Khindri3 GSK, Respiratory Research and Development, Middlesex, UK
, Mitra Vahdati-Bolouri3 GSK, Respiratory Research and Development, Middlesex, UK
, Alison Church4 GSK, Respiratory and Immuno-Inflammation Research, Triangle Park, NC, USA
, William A Fahy3 GSK, Respiratory Research and Development, Middlesex, UK
& Roopa Trivedi4 GSK, Respiratory and Immuno-Inflammation Research, Triangle Park, NC, USA;5 Pearl Therapeutics Inc., Durham, NC, USA
show all
Pages 719-730
|
Published online: 07 Apr 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.